Status:
NOT_YET_RECRUITING
Connected Prehabilitation Program During Neo Adjuvant Chemotherapy
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
NACT is a heavy oncologic treatment, which can impair functional capacity, nutritional and emotional status. These three impairments are often ignored and not taken into account in the pre-therapeutic...
Detailed Description
The main objective will be to determine if a prehabilitation program during NACT, for patients treated for an advanced ovarian cancer will limit physical alteration before major abdomino-pelvic surger...
Eligibility Criteria
Inclusion
- Patient must have signed the written consent,
- Age ≥ 18 years,
- Patient with advanced ovarian cancer (AOC), FIGO Stage III - IV, undergoing surgery,
- Patient with neo adjuvant chemotherapy (min 3 cycles, max 6 cycles),
- Capability to perform a cardiopulmonary exercise test (CPET)
- Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen.
Exclusion
- Patient with cognitive impairment,
- Pregnancy,
- Neoadjuvant treatment contraindications,
- Physical adapted activity program contraindication,
- No possibility to have access to connected devices or do not have a smartphone or a computer
- Patient deprived of liberty or placed under the authority of a tutor,
- Patient considered socially or psychologically unable to comply with the procedure and the required medical follow-up.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT04451369
Start Date
May 1 2021
End Date
September 1 2027
Last Update
February 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.